Kaushik Patra

985 total citations
18 papers, 718 citations indexed

About

Kaushik Patra is a scholar working on Pathology and Forensic Medicine, Statistics and Probability and Rheumatology. According to data from OpenAlex, Kaushik Patra has authored 18 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Statistics and Probability and 4 papers in Rheumatology. Recurrent topics in Kaushik Patra's work include Rheumatoid Arthritis Research and Therapies (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Kaushik Patra is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Kaushik Patra collaborates with scholars based in United States, Canada and United Kingdom. Kaushik Patra's co-authors include Edward Keystone, Jörn Drappa, Erik Pulkstenis, Dipak K. Dey, Eliezer Katz, Armando Flor, Robert A. Gasser, Mark Penney, Paul Newbold and René van der Merwe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Neurology.

In The Last Decade

Kaushik Patra

18 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaushik Patra United States 12 265 235 223 209 145 18 718
Roos J. Leguit Netherlands 19 101 0.4× 69 0.3× 209 0.9× 77 0.4× 116 0.8× 43 887
Ayan Das Gupta India 12 374 1.4× 253 1.1× 155 0.7× 69 0.3× 158 1.1× 33 745
Lilianne Kim United States 11 492 1.9× 458 1.9× 222 1.0× 63 0.3× 264 1.8× 25 853
Orlando Gabriel Carballo Argentina 9 216 0.8× 433 1.8× 286 1.3× 33 0.2× 47 0.3× 19 753
Annette M. May Germany 14 125 0.5× 77 0.3× 52 0.2× 60 0.3× 258 1.8× 35 559
Saskia Vosslamber Netherlands 18 340 1.3× 475 2.0× 166 0.7× 33 0.2× 71 0.5× 32 838
Bernie Scallon Sweden 5 234 0.9× 200 0.9× 21 0.1× 84 0.4× 84 0.6× 6 639
Tomáš Papajík Czechia 16 215 0.8× 38 0.2× 383 1.7× 53 0.3× 119 0.8× 109 792
Rekha Parmar United Kingdom 12 387 1.5× 416 1.8× 55 0.2× 45 0.2× 105 0.7× 23 779
Paulo Luiz Carvalho Francescantônio Brazil 9 228 0.9× 418 1.8× 238 1.1× 35 0.2× 32 0.2× 15 715

Countries citing papers authored by Kaushik Patra

Since Specialization
Citations

This map shows the geographic impact of Kaushik Patra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaushik Patra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaushik Patra more than expected).

Fields of papers citing papers by Kaushik Patra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaushik Patra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaushik Patra. The network helps show where Kaushik Patra may publish in the future.

Co-authorship network of co-authors of Kaushik Patra

This figure shows the co-authorship network connecting the top 25 collaborators of Kaushik Patra. A scholar is included among the top collaborators of Kaushik Patra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaushik Patra. Kaushik Patra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Thomas, Janet, Wen‐Hann Tan, Aneal Khan, et al.. (2024). Long-term safety and efficacy of DTX301 in adults with late-onset ornithine transcarbamylase (OTC) deficiency: A Phase 1/2 trial. Molecular Genetics and Metabolism. 141(4). 108266–108266. 1 indexed citations
3.
Genge, Angela, Leonard H. van den Berg, Glen Frick, et al.. (2023). Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis. JAMA Neurology. 80(10). 1089–1089. 11 indexed citations
4.
5.
Lipkovich, Ilya, Alex Dmitrienko, Kaushik Patra, Bohdana Ratitch, & Erik Pulkstenis. (2017). Subgroup Identification in Clinical Trials by Stochastic SIDEScreen Methods. Statistics in Biopharmaceutical Research. 9(4). 368–378. 5 indexed citations
6.
7.
Sands, Bruce E., Jingjing Chen, Brian G. Feagan, et al.. (2017). Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study. Gastroenterology. 153(1). 77–86.e6. 223 indexed citations
8.
Pulkstenis, Erik, Kaushik Patra, & Jianliang Zhang. (2017). A Bayesian paradigm for decision-making in proof-of-concept trials. Journal of Biopharmaceutical Statistics. 27(3). 442–456. 8 indexed citations
9.
Schiopu, Elena, Soumya Chatterjee, Vivien Hsu, et al.. (2016). Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study. Arthritis Research & Therapy. 18(1). 131–131. 60 indexed citations
10.
Patra, Kaushik, Bruce Cree, Eliezer Katz, et al.. (2016). Statistical Considerations for an Adaptive Design for a Serious Rare Disease. Therapeutic Innovation & Regulatory Science. 50(3). 375–384. 2 indexed citations
11.
Cree, Bruce, Jeffrey L. Bennett, Mark Sheehan, et al.. (2015). Placebo-controlled study in neuromyelitis optica—Ethical and design considerations. Multiple Sclerosis Journal. 22(7). 862–872. 52 indexed citations
12.
13.
Keystone, Edward, Arthur Kavanaugh, Michael E. Weinblatt, Kaushik Patra, & Aileen L. Pangan. (2011). Clinical Consequences of Delayed Addition of Adalimumab to Methotrexate Therapy Over 5 Years in Patients with Rheumatoid Arthritis. The Journal of Rheumatology. 38(5). 855–862. 24 indexed citations
14.
Heijde, Désirée van der, Ferdinand C. Breedveld, Arthur Kavanaugh, et al.. (2010). Disease Activity, Physical Function, and Radiographic Progression After Longterm Therapy with Adalimumab Plus Methotrexate: 5-Year Results of PREMIER. The Journal of Rheumatology. 37(11). 2237–2246. 73 indexed citations
15.
Emery, Paul, Mark C. Genovese, Ronald van Vollenhoven, et al.. (2009). Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis. The Journal of Rheumatology. 36(7). 1429–1441. 81 indexed citations
16.
Jamal, Shahin, Kaushik Patra, & Edward Keystone. (2008). Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis. Clinical Rheumatology. 28(4). 413–419. 27 indexed citations
17.
Patra, Kaushik & Dipak K. Dey. (2002). A General Class of Change Point and Change Curve Modeling for Life Time Data. Annals of the Institute of Statistical Mathematics. 54(3). 517–530. 12 indexed citations
18.
Patra, Kaushik & Dipak K. Dey. (1999). A multivariate mixture of Weibull distributions in reliability modeling. Statistics & Probability Letters. 45(3). 225–235. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roos J. Leguit Breakdown of academic impact, for papers by Ayan Das Gupta Breakdown of academic impact, for papers by Lilianne Kim Breakdown of academic impact, for papers by Orlando Gabriel Carballo Breakdown of academic impact, for papers by Annette M. May Breakdown of academic impact, for papers by Saskia Vosslamber Breakdown of academic impact, for papers by Bernie Scallon Breakdown of academic impact, for papers by Tomáš Papajík Breakdown of academic impact, for papers by Rekha Parmar Breakdown of academic impact, for papers by Paulo Luiz Carvalho Francescantônio
Rankless by CCL
2026